Molecular and genetic markers of follicular-cell thyroid cancer: Etiology and diagnostic and therapeutic opportunities

Keyphrases

• Molecular Markers 100%
• Genetic Markers 100%
• Therapeutic Potential 100%
• Thyroid Cancer 100%
• Cancer Diagnostics 100%
• Follicular Cells 100%
• Anaplastic Thyroid Cancer 100%
• Cancer Etiology 100%
• Survival Rate 50%
• Molecular Etiology 50%
• Papillary Thyroid Carcinoma 50%
• Metastasis 25%
• Tumor Progression 25%
• Mitogen-activated Protein Kinase 25%
• Cell-derived 25%
• 5-year Survival 25%
• US Population 25%
• Median Survival 25%
• Oncogene 25%
• Papillary 25%
• Increased Incidence 25%
• Molecular Targets 25%
• Cellular Origin 25%
• Recurrence Rate 25%
• Differentiated Thyroid Cancer 25%
• Aggressive Tumor 25%
• Tumor Formation 25%
• Genetic Etiology 25%
• Multiple Signaling Pathways 25%
• Proclivity 25%
• Thyroid Carcinoma 25%
• Papillary Thyroid Cancer 25%
• Radioactive Iodine 25%
• Genetic Targets 25%

Medicine and Dentistry

• Diagnosis 100%
• Thyroid Cancer 100%
• Anaplastic Thyroid Carcinoma 100%
• Molecular Marker 100%
• Papillary Thyroid Cancer 75%
• Survival Rate 50%
• Cancer 50%
• Neoplasm 25%
• Carcinogenesis 25%
• Tumor Progression 25%
• Metastatic Carcinoma 25%
• Cell Signaling Pathway 25%
• Recurrent Disease 25%
• Mitogen-Activated Protein Kinase 25%
• Oncogene 25%
• Differentiated Thyroid Cancer 25%
• Thyroid Carcinoma 25%
• Thyroid Tumor 25%
• Radioactive Iodine 25%
• Molecular Pathology 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Thyroid Cancer 100%
• Anaplastic Thyroid Carcinoma 100%
• Thyroid Papillary Carcinoma 75%
• Survival Rate 50%
• Neoplasm 25%
• Carcinogenesis 25%
• Tumor Growth 25%
• Mitogen Activated Protein Kinase 25%
• Recurrent Disease 25%
• Differentiated Thyroid Cancer 25%
• Radioactive Iodine 25%
• Molecular Pathology 25%
• Thyroid Tumor 25%
• Thyroid Carcinoma 25%